NCT06725004 2025-08-29
Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 3 Completed
Clinical Trials
13 trialsNCT02436226 2023-10-31
Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS
Mansoura University
Phase 4 Completed
NCT04727671 2023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
Damascus University
Phase 4 Completed
NCT04727684 2023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
Damascus University
Phase 4 Completed
NCT04071574 2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2 Completed
NCT05112692 2021-11-09
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
Mansoura University
Phase NA Unknown
NCT00747617 2018-11-21
Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
University of California, San Diego
Phase 3 Completed
NCT01815138 2018-10-26
Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
UConn Health
Phase 4 Completed
NCT00989781 2018-06-04
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
University of California, San Diego
Phase NA Completed
NCT01653743 2016-01-07
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT02551367 2015-09-16
LVCCFOROI
Ain Shams Maternity Hospital
Phase 2 Unknown
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT00947713 2011-07-15
Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome
Royan Institute
Phase 1/2 Completed